Open Health Tools Initiative Targets 2009 for Major Release


By Maureen McKinney

April 15, 2008 | After two years of planning, a new open source collaborative site called Open Health Tools (OHT) is available to users, and will eventually offer a wide range of free tools and software for expediting EHR implementation and facilitating interoperability, says Skip McGaughy, OHT’s executive director. The goal is to have many of the tools up and running by early 2009 according to McGaughy.

On April 8, OHT announced support from a number of government health care consumers such as the United Kingdom’s National Health Service (NHS), the U.S. Department of Veteran Affairs (VA), and Australia’s National E-Health Transition Authority. OHT also has a stable of standards organizations — among them HL7 and the International Health Terminology Standards Development Organisation — and a large group of vendors including Oracle, IBM, Inpriva, and B2 International.

“The problem we are trying to solve is the need to bring information from very divergent sources to health care providers and clinicians, and this requires a collaborative community to help design, develop, and deploy the technology for interoperability,” explained McGaughy, who was also one of the original founders of Eclipse Foundation, another open source community. The model for OHT is based on Eclipse’s platform, he added.

When OHT’s tool suite is complete, it will include the Common Health Interoperability Framework, as well as adapters and transformers that will enable users to bring legacy data into an interoperable network. That is an essential component, according to McGaughy, because in addition to new tooling and applications, the platform has to provide methods for integrating existing records.

The site will also offer free technology for enhancing security and privacy of patient information, and tools that will enable web reporting. One of the greatest advantages offered by the free software is that it affords vendors the time to focus on other projects while still adding important features to their solutions.

For instance, one of the tools currently available is code from NHS that will help users to implement HL7 messaging. If a vendor picks up the code and embeds it in their product, they are not obligated to give any credit to OHT or NHS, and are free to brand and distribute their solution in any way they choose. Vendors can also feel secure taking code from the platform because it’s already been exhaustively tested, McGaughy said.

“The odds are that if two vendors are in competition with one another, the second vendor will also embed that HL7 messaging code in their solution because there are no restrictions,” he explained. “Then those two vendors can interoperate using that code. We’ve seen with the Eclipse model that if you provide high quality, free software with minimal restrictions, it does work.”

For the first major charter project, members will head up different projects to develop a variety of software and tools concurrently. For instance, the NHS has contributed the HL7 messaging code, and has also added an XML processing engine.

Oregon State University is hosting OHT’s site and all of its downloadable activities, and will also provide tools that verify interoperability standards.

“We’ve got academic institutions, commercial vendors, standards organizations, and consumers — all of whom bring very diverse backgrounds and interests to the table,” McGaughy said. “There’s no reason why we can’t provide systems that interoperate.”

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.